Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: A report from the Children's Cancer Group

Journal of Clinical Oncology

Volumn 20, Issue 2, 2002, Pages 434-440

  Woods, William G ^a   Barnard, Dorothy R ^a   Alonzo, Todd A ^a   Buckley, Jonathan D ^a   Kobrinsky, Nathan ^a   Arthur, Diane C ^a   Sanders, Jean ^a   Neudorf, Steven ^a   Gold, Stuart ^a   Lange, Beverly J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; MYELOMONOCYTIC LEUKEMIA; PRELEUKEMIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFRACTORY ANEMIA; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037080290     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.20.2.434     Document Type: Article

References (31)

1. Proposals for the classification of the myeloid dysplastic syndromes
2. Juvenile myelomonocytic leukemia
3. Pediatric myelodysplasia: A study of 68 children and a new prognostic scoring system
4. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes
5. The myelodysplastic syndromes: Biology and implications for management
6. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Childrens Cancer Group pilot study
7. The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia
8. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia
9. An update on allogeneic marrow transplantation for myelodysplastic syndrome
10. Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: A long-term study of 71 patients Societe Francaise de Greffe de Moelle
11. Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute non-lymphocytic leukemia (ANLL)
12. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
13. The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia
14. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Childrens Cancer Group study
15. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation and aggressive chemotherapy in children with acute myeloid leukemia in remission: A report from the Children's Cancer Group
16. Asymptotically efficient rank invariant test procedures
17. Nonparametric estimation from incomplete observations
18. Revised classification of acute myeloid leukemia
19. Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: A Cancer and Leukemia Group B study
20. Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy
21. Myelodysplastic syndromes in childhood: Report of 21 patients from Italy and West Germany
22. The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-T
23. Intensive chemotherapy in childhood myelodysplastic syndrome: A comparison with results in acute myeloid leukemia
24. Use of partially mismatched related donors extends access to allogeneic marrow transplant
25. Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia
26. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia
27. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease
28. Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients
29. Childhood monosomy 7: Epidemiology, biology, and mechanistic implications
30. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia